Skip to main content
logo
Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
21.83
-0.46 (-2.06%)
At close: Mar 24, 2026, 4:00 PM EDT
22.00
+0.17 (0.78%)
After-hours: Mar 24, 2026, 7:41 PM EDT

Arcutis Biotherapeutics Revenue

In the year 2025, Arcutis Biotherapeutics had annual revenue of $376.07M with 91.34% growth. Arcutis Biotherapeutics had revenue of $129.50M in the quarter ending December 31, 2025, with 81.48% growth.

Revenue (ttm)
$376.07M
Revenue Growth
+91.34%
P/S Ratio
7.20
Revenue / Employee
$1,062,350
Employees
354
Market Cap
2.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025376.07M179.53M91.34%
Dec 31, 2024196.54M136.94M229.74%
Dec 31, 202359.61M55.92M1,517.09%
Dec 31, 20223.69M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Telix Pharmaceuticals803.79M
Catalyst Pharmaceuticals588.99M
Travere Therapeutics490.73M
Tarsus Pharmaceuticals451.36M
Arcus Biosciences247.00M
IDEAYA Biosciences218.71M
Beam Therapeutics139.74M
Viridian Therapeutics70.85M
Revenue Rankings

ARQT News

More News